Examples of using Cardiac dysfunction in English and their translations into German
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Ecclesiastic
-
Political
-
Computer
-
Programming
-
Official/political
-
Political
Cardiac dysfunction see section 4.4.
Wnt/β-catenin activation results in the development of cardiac dysfunction.
Cardiac dysfunction is a known complication of severe iron overload.
Therefore, caution should be exercised in patients with cardiac dysfunction.
The cardiac dysfunction may be due to myocardial, rhythmologic, or mechanical causes Figure 1.
Monitoring may help to identify patients who develop cardiac dysfunction.
Patients who develop asymptomatic cardiac dysfunction may benefit from more frequent monitoring e.g. every 6- 8 weeks.
Patients who receive anthracyclines after stopping Herceptinmay possibly be at increased risk of cardiac dysfunction.
In the event of elderly patients with mild to moderate cardiac dysfunction requiring therapy, special care and follow up is warranted.
The risks and benefits of pazopanib should be considered before beginning therapy in patients who have pre-existing cardiac dysfunction.
Many experiencing Lymedisease heart problems have no prior cardiac dysfunction and no persistent problems after treatment for the infection.
On the other hand,an inadequate rise in blood pressure may indicate cardiac dysfunction e.g., systolic heart failure or arterial hypertension.
Patients with chronic cardiac dysfunction are advised to start taking Nebivolol with a quarter of the tablet(1.25 mg), doubling the dose with good tolerability.
The safety of continuation or resumption of Herceptin in patients who experience cardiac dysfunction has not been prospectively studied.
Most of the patients(79%) who developed cardiac dysfunction in these trials experienced an improvement after receiving standard treatment for CHF.
Patients treated with Herceptin are at increased risk for developing CHF(New York Heart Association[NYHA] Class II-IV)or asymptomatic cardiac dysfunction.
When using the"Ascoril"(reviewsof patients confirm this), cardiac dysfunction, such as increased heart rate, lowering blood pressure, may develop.
Cardiac dysfunction may be caused by an enlarged or dilated heart muscle, compression of the lining of the heart, outflow obstructions, blood clot, severe heart disease, heartworm disease, or severe arrhythmias.
Compromised renal or hepatic function and especially cardiac dysfunction are more likely in the elderly and therefore medically appropriate supervision should be maintained.
Risk factors: Thirteen of the 15 subjects in the pazopanib arm of the STS phase III study hadconcurrent hypertension which may have exacerbated cardiac dysfunction in patients at risk by increasing cardiac after- load.
Patients with chronic cardiac dysfunction are advised to start taking Nebivolol with a quarter of the tablet(1.25 mg), doubling the dose with good tolerability.
According to animal research at the National Institute on Alcohol Abuse and Alcoholism in Bethesda, USA,activation of the cannabinoid-1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy.
Patients with significant cardiac dysfunction(congestive heart failure[NY Heart Association Class III or IV]; myocardial infarction within 12 months of starting study; unstable or poorly controlled angina pectoris) were excluded from clinical studies with pomalidomide.
Amongst the most serious and/or common adverse reactions reported in Herceptin usage(intravenous and subcutaneous formulations)to date are cardiac dysfunction, administration-related reactions, haematotoxicity(in particular neutropenia), infections and pulmonary adverse reactions.
Science: CB1 receptor activation may promote diabetic cardiomyopathy According to animal research at the National Institute on Alcohol Abuse and Alcoholism in Bethesda, USA,activation of the cannabinoid-1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy.
These were reported as adverse events less frequently by investigators than asindicated by laboratory value tables. g Cardiac dysfunction events- includes Left ventricular dysfunction, Cardiac failure and Restrictive cardiomyopathy h Frequency is based on adverse events reported by investigators.
The following terms have been combined: a Abdominal pain, abdominal pain upper and abdominal pain lower b Oedema, oedema peripheral, eye oedema, localised oedema and face oedema c Dysgeusia, ageusia and hypogeusia d White cell count decreased, neutrophil count decreased and leukocyte count decreased e Decreased appetite andanorexia f Cardiac dysfunction, left ventricular dysfunction, cardiac failure and restrictive cardiomyopathy g Venous thromboembolic event, deep vein thrombosis, pulmonary embolism and thrombosis.
The most important serious adverse reactions identified in the RCC or STS trials were transient ischaemic attack, ischaemic stroke, myocardial ischaemia,myocardial and cerebral infarction, cardiac dysfunction, gastrointestinal perforation and fistula, QT prolongation and pulmonary, gastrointestinal and cerebral haemorrhage, all adverse reactions being reported in< 1% of treated patients.
Science: Dysfunction of the heart According to research at the National Institutes of Healthin Bethesda, USA, the natural cannabinoid CBD(cannabidiol) attenuates cardiac dysfunction, oxidative stress, fibrosis, inflammation and cell death in animal models of diabetic cardiomyopathy.